Development of pH-independent drug release formulation using Lipocalin-type prostaglandin D synthase
M Mizoguchi, M Nakatsuji, J Takano, O Ishibashi… - Journal of …, 2016 - Elsevier
The purpose of this study was to develop a pH-independent drug release formulation using
lipocalin-type prostaglandin D synthase, a member of the lipocalin superfamily, with the …
lipocalin-type prostaglandin D synthase, a member of the lipocalin superfamily, with the …
[PDF][PDF] Application of lipocalin-type prostaglandin D synthase (L-PGDS) as a novel solubilizer for solid oral dosage forms
溝口雅之 - 2016 - omu.repo.nii.ac.jp
According to the recent approach shift for drug discovery from the phenotypic to target-based
approach, only the efficacy of candidate is focused and the candidate proceeding to the next …
approach, only the efficacy of candidate is focused and the candidate proceeding to the next …